http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8701282-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d30ad294786868bb6a8b51400e42c51c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 1986-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4b8d50eb2919037d2fe571e4c93669e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a4932d3a5cc4c037460632ac3a8d07
publicationDate 1987-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-8701282-A2
titleOfInvention Method and composition for providing sustained opioid antagonism
abstract Prolonged opioid antagonism is provided by injection of the compound 6-methylene-6-desoxy-N-cyclopropylmethyl-14-hydroxydihydronormorphine. Such injection is useful for a variety of remedial and prophylactic uses. An injectable dosage form of the compound 6-methylene-6-desoxy-N-cyclopropylmethyl-14-hydroxydihydronormorphine can be provided in a kit form with instructions as to use.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685443-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10092519-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877247-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9907793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10258235-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7682634-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9655855-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10420762-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9949930-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8623418-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846104-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8158156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9820983-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9084729-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7682633-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9056051-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10071089-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10350173-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10588865-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9801828-B2
priorityDate 1985-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8303197-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-769517-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0144243-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128178362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141769606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128925071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128851630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129588878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413574287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129659418
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284371

Total number of triples: 56.